Showing results (361-370 of 2,105) with videos related to
Sort By:
Pageof 211
CNS Drugs|August 21, 2023
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA SystemEmilio Perucca, Meir Bialer, H Steve WhiteCNS Drugs|August 21, 2023
Over the Counter Supplements for Memory: A Review of Available EvidenceHaley Hersant, Sean He, Peter Maliha, et al.CNS Drugs|October 4, 2023
Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical TrialsDania Akbar, Taeho Greg Rhee, Felicia Ceban, et al.CNS Drugs|July 20, 2023
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer's DiseaseSolana Leisher, Adriana Bohorquez, Marcus Gay, et al.CNS Drugs|January 29, 2019
Novel Treatment Opportunities Against Cognitive Impairment in Parkinson's Disease with an Emphasis on Diabetes-Related PathwaysHolly Green, Panagiota Tsitsi, Ioanna Markaki, et al.CNS Drugs|December 5, 2018
Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Parkinson's DiseasesAndre F Batista, Victor Bodart-Santos, Fernanda G De Felice, et al.CNS Drugs|January 19, 2020
Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 StudyRobert T Naismith, Annette Wundes, Tjalf Ziemssen, et al.CNS Drugs|December 28, 2019
Pharmacotherapy for Pediatric Convulsive Status EpilepticusAvantika Singh, Coral M Stredny, Tobias LoddenkemperCNS Drugs|March 29, 2020
Efficacy, Tolerability, and Safety of Concentrated Intranasal Midazolam Spray as Emergency Medication in Epilepsy Patients During Video-EEG MonitoringAnemone von Blomberg, Lara Kay, Susanne Knake, et al.Pageof 211